Drug Research
AbbVie, Gilgamesh Pharma Partner on Next-Gen Psychiatric Therapies
AbbVie and Gilgamesh Pharmaceuticals entered a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise in psychiatry...
Drug Research
Fulcrum Enters Collaboration & License Agreement with Sanofi
Fulcrum Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing small molecules, has entered into a collaboration and license agreement with Sanofi for the development...
Drug Research
Aldevron, Acuitas Partner to Expand Capabilities in mRNA LNP...
Aldevron, a global manufacturer of DNA, RNA, and proteins used in cell and gene therapies and vaccine development, has entered a strategic partnership with Acuitas...
Drug Research
Abzena Launches EpiScreen 2.0, a Next Generation Immunogenicity Tool...
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its enhanced bioassay platform EpiScreen® 2.0, a comprehensive suite of assays...
Drug Research
ChargePoint to expand product range by investing in a...
ChargePoint Technology, a specialist in powder and liquid transfer, has invested in a new manufacturing facility dedicated to its single-use products in Speke, Liverpool, to...
Drug Research
EMA Offers Plans To Enhance Availability of Vital Medicines
As the EU health ministers go on to gather in Brussels on April 23–24 in order to discuss access when it comes to critical medicines...
Drug Research
Market Trends: Biologics Clinical Manufacturing CDMO Service
In the ever-changing pharma and biologics sector, the Biologics Clinical Manufacturing CDMO Service market has gone on to emerge as quite a prominent player in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.